Why Bigtincan shares could be a small-cap buy

Bigtincan Holdings Ltd (ASX:BTH) is in the CRM space and has deals with Salesforce and Adobe.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Bigtincan Holdings Ltd (ASX: BTH) share price is up 15% to 53 cents this morning after the software-as-a-service (SaaS) business announced upgraded revenue guidance and a new sales partnership.

For fiscal 2019 Bigtincan previously guided for revenue growth between 35%-40%, however, it now sees revenue growth above 40% thanks to new customer wins and up-selling to existing customers.

Bigtincan also announced it has partnered with U.S. tech giant Adobe to integrate its software into its platform and Bigtincan is now partnered with both Adobe and Salesforce as the two undisputed kings of the online CRM (customer relationship management) platforms.

Salesforce in particular has delivered knockout growth over the past decade thanks to its adoption of a cloud (online only) sales platform that it offers on a subscription basis to enterprise clients of all sizes.

A CRM platform allows a business to track customer interactions, sales, disputes, etc, and hopefully improve sales and efficiencies.

In other words when you talk to a call centre or order something online from a business the order with all your details on is often recorded on a clever CRM platform like that offered by Salesforce.

Bigtincan also offers a sales enablement (CRM) platform of sorts that is being rapidly adopted.

It also boasts all the attractive economics of SaaS businesses (recurring revenues, growing LTVs, ARPUs, etc) and a decent balance sheet, although for the six months ending December 31 2018 it posted a loss of $1.95 million.

As such it looks worth further investigation as it could be a potential buy for small-cap enthusiasts, while more conservative investors would prefer the market dominance and growth of something like NYSE-listed Salesforce.

Motley Fool contributor Tom Richardson has no position in any of the stocks mentioned. You can find Tom on Twitter @tommyr345 The Motley Fool Australia has recommended BIGTINCAN FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 broke its losing streak to inch higher today.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Consumer Staples & Discretionary Shares

Bapcor shares soar 12% on the appointment of a new CEO

The market’s strong reaction reflects a clear message: investors are ready for a reset.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why Bapcor, IDP Education, Netwealth, and Ora Banda shares are pushing higher today

These shares are catching the eye with solid gains on Thursday. But why are they rising?

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was another woeful day for investors this Wednesday.

Read more »